Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type 2 diabetes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Diabet. Med. 29, 1562–1566 (2012) Aim To investigate the association between nephropathy and HbA 1c variability (assessed as the standard deviation of each patient’s HbA 1c measurements) among patients with Type 2 diabetes. Methods Albumin excretion rate and HbA 1c were measured in 2103 patients followed up for a mean 6.6 years. Multivariate Cox regression analysis was used to determine the influence of HbA 1c variability on the risk of progression of nephropathy after adjustment for age, sex, duration of diabetes, baseline condition (two cohorts defined by duration of diabetes, retinopathy and albumin excretion rate), baseline HbA 1c, insulin use, BMI, use of anti‐hypertensive agents, smoking, lipid status, retinopathy, updated mean HbA 1c and number of HbA 1c measurements. Results Nephropathy progressed in 18.3% of subjects. HbA 1c variability was significantly greater among progressors than among non‐progressors (12 vs. 10 mmol/mol; 1.12 vs. 0.90%; P < 0.0001) and was a significant predictor of progression of nephropathy even after adjustment for updated mean HbA 1c and other risk factors (hazard ratio 1.37, 95% CI 1.12–1.69). Conclusion In patients with Type 2 diabetes, the risk of progression of nephropathy increases significantly with HbA 1c variability, independently of the influence of updated mean HbA 1c.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Hoelzel, W., Weykamp, C., Jeppsson, J.-O., Miedema, K., Barr, J. R., Goodall, I., Hoshino, T., John, W. G., Kobold, U., Little, R., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024802 · Cited by 690
A desktop guide to Type 2 diabetes mellitus
European Diabetes Policy Group, 1. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00166.x · Cited by 670
A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008) · Diabetes Care · doi:10.2337/dc08-0864 · Cited by 420
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Service, F. J., & O'Brien, P. C. (2001) · Diabetologia · doi:10.1007/s001250100635 · Cited by 106
Cited by
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
Gorst, C., Kwok, C. S., Aslam, S., Buchan, I., Kontopantelis, E., Myint, P. K., Heatlie, G., Loke, Y., Rutter, M. K., & Mamas, M. A. (2015) · Diabetes Care · doi:10.2337/dc15-1188 · Cited by 530
Hirakawa, Y., Arima, H., Zoungas, S., Ninomiya, T., Cooper, M., Hamet, P., Mancia, G., Poulter, N., Harrap, S., Woodward, M., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0199 · Cited by 363
Cardoso, C. R. L., Leite, N. C., Moram, C. B. M., & Salles, G. F. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0677-0 · Cited by 222
Clinical predictive factors in diabetic kidney disease progression
Radcliffe, N. J., Seah, J., Clarke, M., MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12533 · Cited by 208
“Rodriguez et al.123 found that, even adjusting for a broad range of other clinical variables, there was a significantly higher risk of increased albumin excretion in patients with type 2 diabetes mellitus with greater HbA1c variability.”
BackgroundScott, E. S., Januszewski, A. S., O’Connell, R., Fulcher, G., Scott, R., Kesaniemi, A., Wu, L., Colagiuri, S., Keech, A., & Jenkins, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa361 · Cited by 70
Metadata
- Authors
- Rodríguez‐Segade, S., Rodríguez, J., García López, J. M., Casanueva, F. F., & Camiña, F.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2012-11-14
- Volume
- 29
- Issue
- 12
- Pages
- 1562-1566
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1590190643
- Cited by
- 43
- References
- 7
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.